2002-2010年業績

2010

1
Miyoshi N. Ishii H., Nagai K., Hoshino H., Mimori K., Tanaka F., Nagano H., Sekimoto M., Doki Y., Mori M. Defined factors induced reprogramming of gastrointestinal cancer cells Proc Natl Acad Sci 107(1):40-45,2010.

2
Takeno A. Takemasa I., Seno S., Yamasaki M., Motoori M., Miyata H., Nakajima K., Takiguchi S., Fujiwara Y., Nishida T., Okayama T., Matsubara K., Takenaka Y., Matsuda H., Monden M., Mori M., Doki Y. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer. Ann Surg Oncol. 17(4):1033-1042,2010.

3
Adachi S. Takiguchi S., Okada K., Yamamoto K., Yamasaki M., Miyata H., Nakajima K., Fujiwara Y., Hosoda H., Kangawa K., Mori M., Doki Y. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 138(4):1312-1320,2010.

4
Miyata H. Yamasaki M., Takiguchi S., Nakajima K., Fujiwara Y., Mori M., Doki Y. Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation. Oncol Rep 23(5):1331-1337,2010.

5
Makino T. Yamasaki M., Miyata H., Yoshioka S., Takiguchi S., Fujiwara Y., Nakajima K., Nishida T., Mori M., Doki Y. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Ann Surg Oncol 17(3):804-811,2010.

6
Yamasaki M. Miyata H., Fujiwara Y., Takiguchi S., Nakajima K., Nishida T.,Yasuda T.,Matsumiya J., Mori M., Doki Y. p53 Genotype Predicts Response to Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus. Ann Surg Oncol 17(2):634-642,2010.

7
Deguchi T. Tanemura M., Miyoshi E., Nagano H., Machida T., Ohmura Y., Kobayashi S., Marubashi S., Eguchi H., Takeda Y., Ito T., Mori M., Doki Y., Sawa Y. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer. Cancer Res70(13):5259-5269,2010.

8
Yamamoto K. Takiguchi S., Miyata H., Adachi S., Hiura Y., Yamasaki M., Nakajima K., Fujiwara Y., Mori M., Kangawa K., Doki Y. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery148(1):31-38,2010.

9
Fujiwara Y. Nishida T., Takiguchi S., Nakajima K., Miyata H., Yamasaki M., Yamamoto K., Moon JH., Mori M., Doki Y. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination. Anticancer Res. 30(4):1335-1340,2010.

10
Rahadiani N. Ikeda J., Makino T., Tian T., Qiu Y., Mamat S., Wang Y., Doki Y., Aozasa K., Morii E. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg Oncol. 17(5):1311-1323,2010.

11
Makino T. Fujiwara Y., Takiguchi S., Miyata H., Yamasaki M., Nakajima K., Nishida T., Mori M., Doki Y. The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients. Surgery 148(1):96-102,2010.

12
Miyoshi N. Ishii H.,  Mimori K., Tanaka F., Kim H., Nagai K., Uemura M., Sekimoto M., Doki Y., Mori M. ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer Oncol Rep 23(2):505-510,2010.

13
Miyoshi N. Ishii H.,  Mimori K., Sekimoto M., Doki Y., Mori M. TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer Int J Oncol 36(3):563-568,2010.

14
Motoyama K. Inoue H., Mimori K., Tanaka F., Kojima K., Uetake H., Sugihara K., Mori M. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer Int J Oncol 36(5):1089-1095,2010.

15
Iwatsuki M. Mimori K., Sato T., Toh H., Yokobori T., Tanaka F., Ishikawa K., Baba H., Mori M. Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance Int J Oncol 36(3):569-575,2010.

16
Nagahama Y. Ueno M., Haraguchi N., Mori M., Takakura N. PSF3 marks malignant colon cancer and has a role in cancer cell proliferation Biochem Biophys Res Commun 392(2):150-154,2010.

17
Iwatsuki M.Mimori K., Yokobori T., Takatsuno Y., Sato T., Toh H., Onoyama I., Nakayama K., Baba H., Mori M. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer:clinical significance. Int J Cancer. 126(8):1828-1837,2010.

18
Yamamoto H. Hemmi H., Gu JY., Sekimoto M., Doki Y., Mori M. Minute liver metastases from a rectal carcinoid:A case report and review. WJGS. 2(3):89-94,2010.

19
Marubashi S. Nagano H., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Monden M., Doki Y., Mori M. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients. J Clin Pharmacol 50(6):705-709,2010.

20
Miyoshi N. Ishii H., Mimori K., Tanaka F., Hitora T., Tei M., Sekimoto M., Doki Y., Mori M. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer. Ann Surg Oncol. 17(4):967-972,2010.

21
Kobayashi S. Nagano H., Marubashi S., Wada H., Eguchi H., Takeda Y., Tanemura M., Kim T., Doki Y., Mori M. Multidetector computed tomography for preoperative prediction of postsugical prognosis of patients with extrahepatic biliary cancer.J Surg Oncol. 101(5):376-383,2010.

22
Murakami M. Nagano H., Kobayashi S., Wada H., Nakamura M., Marubashi S., Eguchi H., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M. Effects of pre-operative transcatheter arterial chemoembolization for respectable hepatocellular carcinoma:implication of circulating cancer cells by detection of α-fetoprotein mRNA EXPERIMENTAL AND THERAPEUTIC MEDICINE 1(5):485-491,2010.

23
Sekimoto M.Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Doki Y., Mori M. Laparoscopic reoperation of anastomotic leakage after a laparoscopic low anterior resection of the rectum Int J Colorectal Dis 25(5):665-666,2010.

24
Nagai K. Ishii H., Miyoshi N., Hoshino H., Saito T., Sato T., Tomimaru Y., Kobayashi S., Nagano H., Sekimoto M., Doki Y., Mori M. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells. Biochem Biophys Res Commun. 395(2):258-263,2010.

25
Ishii H. Doki Y., Mori M. Perspective beyond cancer genomics:bioenergetics of cancer stem cells. Yonsei Med J. 51(5):617-621,2010.

26
Haraguchi N. Ishii H., Mimori K., Tanaka F., Ohkuma M., Kim MH., Akita H., Takiuchi D., Hatano H., Nagano H., Barnard GF., Doki Y., Mori M. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 120(9):3326-3329,2010.

27
Shimizu S. Takehara T., Hikita H., Kodama T., Miyagi T., Hosui A., Tatsumi T., Ishida H., Noda T., Nagano H., Doki Y., Mori M., Hayashi N. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma Journal of Hepatology 52:698-704,2010.

28
Tokuoka M. Miyoshi N., Hirota T., Mimori K., Tanaka F., Shibata K., Ishii H., Sekimoto M., Doki Y., Mori M. Clinical significance of ASB9 in human colorectal cancer. Int J Oncol 37(5):1105-1111,2010.

29
Motoori M. Takemasa I., Yamasaki M., Komori Y., Takeno A., Miyata H., Takiguchi S., Fujiwara Y., Yasuda T., Yano M., Matuura M.,Matsubara K., Monden M., Mori M., Doki Y. Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples. Int J Oncol 37(5):1113-1120,2010.

30
Nakajima K. Nezu R., Ito T., Nishida T. Hand-Assisted Laparoscopic Restorative Proctocolectomy for Ulcerative Colitis: The Optimization of Instrumentation Toward Standardization Surg Today 40(9):840-844,2010.

31
Tanaka K. Yano M., Motoori M., KIshi K., Miyashiro I., Shingai T., Gotoh K., Nomura S., Takahashi H., Ohue M., Yamada T., Ohigashi H., Yamamoto T., Yamasaki T., Doki Y., Ishikawa O. CEA-Antigen and SCC-Antigen mRNA Expression in Perigheral Blood Predict Hematogenous Recurrence After Resection in Patients with Esophageal Cancer. Ann Surg Oncol 17(10):2779-2786,2010.

32
Yokobori T. Mimori K., Ishii H., Iwatsuki M., Tanaka F., Kamohara Y,. Ieta K., Kita Y., Doki Y., Kawano H., Mori M. Clinical Significance of Stanniocalcin 2 as a Prognostic Marker in Gastric Cancer. Ann Surg Oncol 17(10):2601-2607,2010.

33
Nagahara M. Mimori K., Kataoka A., Ishii H., Tanaka F., Nagahara T., Sato T., Ono S., Sugihara K., Mori M. Correlated Expression of CD47 and SIRPA in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients Correlated Expression of CD47 and SIRPA in Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients Clin Cancer Res 16(18):4625-4635,2010.

34
Yoshimoto K. Namori H., Mori T., Ohba Y., Shibata H., Tashiro K., Shiraishi S., Kobayashi T. A Segmentectomy of the Right Upper Lobe Has an Advantage over a Right Upper Lobectomy Regarding the Preservation of the Functional Volume of the Right Middle Lobe: Analysis by Perfusoin Single-Photon Emission Computed Tomography/Computed Tomography. Surgery Today 40(7):614-619,2010.

35
Ozawa K. Iwatsuki M., Mimori K., Sato T., Johansson F., Toh H., Watanabe M., Mori M. FANCD2 mRNA Overexpression is a Bona Fide Indicator of Lymph Node Metastasis in Human Colorectal Cancer. Ann Srug Oncol 17(9):2341-2348,2010.

36
Yamamoto H. Sekimoto M., Uemura M., Miyoshi N., Haraguchi N., Takemasa I., Nomura M., Mizusgima T., Ikeda M., Doki Y., Mori M. Feasibility of end-to-anterior wall anastomosis in conversion of the double-stapling technipue during laparoscopically assisted surgery. Surg Endosc 24(9):2178-2181,2010.

37
Nakajima K. Nishida T., Milsom JW ., Takahashi T., Souma Y., Miyazaki Y., Iijima H., Mori M., Doki Y. Current limitations in endoscopic CO2 insufflation for NOTES: flow and pressure study. Gastrointest Endosc 72(5):1036-1042,2010.

38
Tanaka F. Yamamoto K., Suzuki S., Inoue H., Tsurumaru M., Kajiyama Y., Kato H., Igaki H., Furuta K., Fujita H., Tanaka T., Tanaka Y., Kawashima Y., Natsugoe S., Setoyama T., Tokudome S., Mimori K., Haraguchi N., Ishii H., Mori M. Strong interaction between the effects of alcohl consumption and smoking on gut squamous cell carcinoma among individuals with ADH1B and/or ADLH2 risk alleles Oesophagus. 59(11):1457-1464,2010.

39
Tanaka F. Mimori K., Tahara K., Inoue H., Mori M. Saline replacement after local resection of breast: a simple technique with good control and improved patient satisfaction. Breast Cancer 17(4):261-264,2010.

40
Ikai I. Kudo M., Arii S., Omata M., Kojiro M., Sakamoto M., Takayasu K., Hayashi N., Makuuchi M., Matsuyama Y., Monden M. Report of the 18th follow-up survey of primary liver cancer in japan. Hepatology 40:1043-1059,2010.

41
Sekimoto M. Takemasa I., Mizushima T., Ikeda M., Yamamoto H., Doki Y., Mori M. Laparoscopic lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery. 25(3):861-866 Surg Endosc 2010.

42
Mizushima T. Ohno Y., Nakajima K., Kai Y., Iijima H., Sekimoto M., Nishida T., Nexu R., Ito T., Doki Y., Mori M. Malignancy in Crohn's disease: incidence and clinical characteristics in Japan. Digestion 81(4):265-270,2010.

43
Tomimaru Y. Eguchi H., Wada H., Noda T., Murakami M., Kobayashi S., Marubashi S., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M., Nagano H. Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells. Br J Cancer 102(10):1483-1490,2010.

44
Tomimaru Y. Nagano H., Eguchi H., Kobayashi S., Marubashi S., Wada H., Tanemura M., Umeshita K., Hiramatsu N., Takehara T., Doki Y., Mori M. Effects of preceding interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 102(4):308-314,2010.

45
Tomimaru Y. Takeda Y., Tatsumi M., Kim T., Kobayashi S., Marubashi S., Eguchi H., Tanemura M., Kitagawa T., Nagano H., Umeshita K., Wakasa K., Doki Y., Mori M. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep 24(3):613-620,2010.

46
Tomimaru Y. Wada H., Marubashi S., Kobayashi S., Eguchi H., Takeda Y., Tanemura M., Noda T., Umeshita K., Doki Y., Mori M., Nagano H. Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol 16(44):5603-5610,2010.

47
Tomimaru Y. Eguchi H., Nagano H., Wada H., Tomokuni A., Kobayashi S., Marubashi S., Takeda Y., Tanemura M., Umeshita K., Doki Y., Mori M MicroRNA-21 induces resistance to the anti-tumor effect of interferon-α /5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer 103(10):1617-1626,2010.

48
Nishimura J. Morii E., Takahashi T., Souma Y., Nakajima K., Doki Y., Nishida T. Abdominal soft tissue sarcoma: a multicenter retrospective study. Int J Clin Oncol 15(4):399-405,2010.

49
Miki Y. Kurokawa Y., Hirao M., Fujitani K., Iwasa Y., Mano M., Nakamori S., Tsujinaka T. Survival analysis of patients with duodenal gastrointestinal stromal tumors. J Clin Gastroenterol 44(2):97-101,2010.

50
Ohmura Y. Tanemura M., Kawaguchi N., Machida T., Tanida T., Deguchi T., Wada H., Kobayashi S., Marubashi S., Eguchi H., Takeda Y., Matsuura N., Ito T., Nagano H., Doki Y., Mori M. Combined Transplantation of Pancreatic Islets and Adipose Tissue-Derived Stem Cells Enhances the Survival and Insulin Function of Islet Grafts in Diabetic Mice. Transplantation 90(12):1366-1373,2010.

51
Shimizu J. Ikeda K., Fukunaga M., Murata K., Miyamoto A., Umeshita K., Kobayashi T., Monden M. Multicenter prospective randomized phase II trial of antimicrobial prophylaxis in low-risk patients undergoing colon surgery. Surgery Today 40(10):954-957,2010.

52
Utsumi M. Shimizu U., Miyamoto A., Umeshita K., Kobayashi T., Monden M., Makimoto K. Age as an independent risk factor for surgical site infections in a large gastrointestinal surgery cohort in Japan. J Hosp Infect 75(3):183-187,2010.

53
Suzuki Y. Takahashi K., Yamaguchi T., Matsumoto H., Nakano D., Koizumi K. Stoma-Closure-Induced Fulminant Pseudomembranous Colitis Recovered by Adjunctive Intracolic Vancomycin with Postural Change. Case Rep Gastroenterol. 4(2):133-137,2010.

54
Mizote Y. Taniguchi T., Tanaka K., Isobe M., Wada H., Saika T., Kita S., Koide Y., Uenaka A., Nakayama E. Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients. Vaccine 19(28):5338-5346,2010.

55
Miyoshi N. Ishii H., Mimori K., Nishida N., Tokuoka M., Akita H., Sekimoto M., Doki Y., Mori M. Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis. Ann Surg Oncol 17(11):3030-3036,2010.

56
Nishida N. Mimori K., Yokobori T., Sudo T., Tanaka F., Shibata K., Ishii H., Doki Y., Mori M. FOXC2 is a Novel Prognostic Factor in Human Esophageal Squamous Cell Carcinoma. Ann Surg Oncol.2010.

57
Miyata H. Yamasaki M., Takiguchi S., Nakajima K., Fujiwara Y., Konishi K., Morii E., Mori M., Doki Y. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg. 2010.

58
Miyata H. Yamasaki M., Kurokawa Y., Takiguchi S., Nakajima K., Fujiwara Y., Konishi K., Mori M., Doki Y. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol.2010.

59
Miyoshi N. Ishii H., Mimori K., Sekimoto M., Doki Y., Mori M. SCRN1 is a novel maeker for prognosis in colorectal cancer. J Surg Oncol 101(2):156-159,2010.

60
Uemura M. Yamamoto H., Takemasa I., Mimori K., Hemmi H., Mizushima T., Ikeda M., Sekimoto M., Matsuura N., Doki Y., Mori M.  Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells. Clin Cancer Res 16(18):4636-4646,2010.

61
Uemura M. Ikeda M., Yamamoto H., Kitani K., Tokuoka M., Matsuda K., Hata Y., Mizushima T., Takemasa I., Sekimoto M., Hosokawa K., Matsuura N., Doki Y., Mori M. Clinicopathological Assessment of Locally Recurrent Rectal Cancer and Relation to Local Re-Recurrence. Ann Surg Oncol. 18(4):1015-1022.2010.

62
Tanida T. Ohue M., Noura S., Seki Y., Gotoh K., Motoori M., Kishi K., Yamada T., Miyashiro I., Ohigashi H., Yano M., Ishikawa O. Long-term complete response of unresectable liver metastases from colorectal cancer. Hepatogastroenterology. 57(101):764-7,2010.

63
Makino T. Miyata H., Yamasaki M., Fujiwara Y., Takiguchi S., Nakajima K., Higuchi I., Hatazawa J., Mori M., Doki Y. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery 148(5):908-918,2010.

64
Rahadiani N. Ikeda J., Makino T., Tian T., Qiu Y., Mamat S., Wang Y., Doki Y., Aozasa K., Morii E. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Ann Surg Oncol 17(5):1311-1323,2010.

65
Qiu Y. Song B., Zhao G., Deng B., Makino T., Tomita Y., Wang J., Luo W., Doki Y., Aozasa K., Morii E. Expression level of Pre B cell leukemia homeobox 2 correlates with poor prognosis of gastric adenocarcinoma and esophageal squamous cell carcinoma. Int J Oncol 36(3):651-663,2010.

66
Nakajima K. Nezu R., Hirota M., Nishida T. The role of hand-assisted laparoscopic surgery in subtotal and total colectomy for Crohn's colitis. Surg Endosc 24(11): 2713- 2717,2010.

67
Tamura S. Miki H., Okada K., Takeno A., Uji K., Yoshida A., Suzuki R., Nakahira S., Egawa C., Nakata K., Okamura S., Sugimoto K., Takatsuka Y. Pilot study of a combintion of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer. Gastric Cancer 13(2): 101- 108,2010.

68
Tamura S. Takiuchi D., Okada K., Takeno A., Miki H., Uji K., Yoshida A., Okamura S., Sugimoto K., Takatsuka Y. A case of esophageal cancer with chronic renal failure undergoing hemodialysis treatment showing long-term complete response with docetaxel chemotherapy and salvage ecdoscopic treatment. Esophagus.7:151-156,2010.

69
Saito M. Kumamoto K., Robles AI., Horikawa I., Furusato B., Okamura S., Goto A., Yamashita T., Nagashima M., Lee T.L., Baxendale V.J., Rennert O.M., Takenoshita S., Yokota J., Sesterhenn I.A., Trivers G.E., Hussain S.P., Harris C.C. Targeted disruption of ing2 results in defective spermatogenesis and development of soft-tissue sarcomas. PLos One.5(11): e15541.

70
Tanaka M. Tanaka M,Takamatsu Y,Anan K,Ohno S,Nishimura R,Yamamoto Y,Masuda N,Mitsuyama S,Tamura K,the Kyushu Breast Cancer Study Group(KBCSG).Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer:aphase Ⅱstudy. Anticancer Drugs. .21(4):453-458.

71
Ohno S. Ohno s,Rai Y,Yamamoto N,Yoshida M,Iwase H,Masuda N,Nakamura S,Taniguchi H,Kamigaki S,Noguchi S. Three dose regimens of fulvestrant in postmenopausal Japanese women with advanced breast cancer:results from a double-blind,phase Ⅱcomparative study(FINDER1). Ann Oncol. 21(12):2342-7. 2010.

72
Taguchi T. Taguchi T., Masuda N., Nakayama T., Motomura K.,Tsukamoto., Shimizu K., Nomura T., Morimoto T., Yamamoto H., Wakita K., Nakano Y., Yoneda K., Inaji H., Takatsuka Y., Noguchi S. Phase Ⅱ Trial in Japan of Sequential administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer(KBCSG0206 Trial:Kinki Breast Cancer Study Group(KBCSG)). Oncology.78(5-6):302-308,2010.

73
Adachi S. Takiguchi S. Okada K. Yamamoto K. Yamasaki M. Miyata H. Nakajima K. Fujiwara Y. Hosoda H. Kangawa K. Mori M. Doki Y. Effects of ghrelin administration after total gastrectomy: A prospective randomized placebo-controlled phase II study. Gastroenterology. 138(4):1312-1320, 2010.

74
Shiomi A. Ito M., Saito N., Hirai T., Ohue M., Kudo Y., Takii Y., Sudo T., Kotake M., Moriya Y. The indications for a diverting stoma in low anterior resection for rectal cancer : a prospective multicentre study of 222 patients from Japanese cancer centers. Colorectal Dis, 13(12):1384-1389 .2010.

75
Shimoi A. Ito M., Saito N., Ohue M., Hirai T., Kudo Y., Moriya Y. A retrospective study of 329 patients from Japanese cancer centers. Int J Colorectal Dis, 26(1):79-87. 2010.

76
Mizushima T. Nomura M, Fujii M, Akamatsu H, Mizuno H, Tominaga H, Hasegawa J, Nakajima K, Yasumasa K, Yoshikawa M, Nishida T. Primary colorectal signet-ring cell carcinoma: Clinicopathological features and postoperative survival. Surgery Today 40(3):234-238,2010.

77
Murakami M. Kobayashi S., Marubashi S., Eguchi H., Takeda Y., Tanemura M., Wada H., Umeshita K., Kennichi W., Doki Y., Mori M., Nagano H. Isolated Metastasis to the Gall Bladder from Hepatocellulor Carcinoma. Hepatol Res 40(8):793-798,2010.